Publications by authors named "Dorothee Boucherle"
Article Synopsis
- * The new formulation, trastuzumab emtansine (T-DM1), links trastuzumab to a cytotoxic drug to enhance delivery to cancer cells and reduce drug resistance.
- * A case study revealed that a patient developed nodular regenerative hyperplasia after 12 months of T-DM1 treatment, leading to the cessation of the drug, though her cancer metastasis worsened; more research is needed on this side effect.